2,3,4′,5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 5, 2012, Pages 429-437

  Zhang, Wei ^a   Chen, Xiang Fan ^a   Huang, Yan Juan ^a   Chen, Qing Qing ^a   Bao, Yuan Jian ^a   Zhu, Weizhong ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

2,3,4 ,5 tetrahydroxystilbene 2 O d glucoside; Angiotensin II; Cardiac fibroblasts; Extracellular signal regulated kinase 1 2; Proliferation; Reactive oxygen species

Indexed keywords

2,3,4',5 TETRAHYDROXYSTILBENE 2 O BETA DEXTRO GLUCOSIDE; ANGIOTENSIN II; BROXURIDINE; CARDIOVASCULAR AGENT; GELATINASE A; GELATINASE B; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; DRUG EFFECT; ENZYME INHIBITION; FIBROBLAST; HEART MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GLUCOSIDES; GROWTH INHIBITORS; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84860250025     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05692.x     Document Type: Article

References (44)

1. Porter KE, Turner NA. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol. Ther. 2009; 123: 255-78.
2. Weber KT, Pick R, Jalil JE, Janicki JS, Carroll EP. Patterns of myocardial fibrosis. J. Mol. Cell. Cardiol. 1989; 21(Suppl. 5): 121-31.
3. Jalil JE, Doering CW, Janicki JS et al. Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J. Mol. Cell. Cardiol. 1988; 20: 1179-87.
4. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ. Res. 1989; 64: 1041-50.
5. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am. J. Physiol. Heart Circ. Physiol. 2005; 288: H1131-8.
6. Chao HH, Chen JJ, Chen CH et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts. Heart 2005; 91: 664-9.
7. Schnee JM, Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc. Res. 2000; 46: 264-8.
8. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998; 32: 488-95.
9. Sano M, Fukuda K, Sato T et al. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 2001; 89: 661-9.
10. Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J. Mol. Cell. Cardiol. 1995; 27: 1151-60.
11. Brilla CG, Scheer C, Rupp H. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J. Hypertens. Suppl. 1997; 15: S13-9.
12. Dostal DE, Booz GW, Baker KM. Angiotensin II signalling pathways in cardiac fibroblasts: Conventional versus novel mechanisms in mediating cardiac growth and function. Mol. Cell. Biochem. 1996; 157: 15-21.
13. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849-61.
14. Stockand JD, Meszaros JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H176-84.
15. Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, Chen JJ. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 2003; 42: 1845-54.
16. Bai HB, Wang JF, Long J. [Study on optimizing extraction process of root of Polygonum multiflorum.] Zhongguo Zhong Yao Za Zhi 2004; 29: 219-21. (in Chinese).
17. Zhang W, Wang CH, Li F, Zhu WZ. 2, 3, 4′, 5-Tetrahydroxystilbene-2-o-β-d-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats. Clin. Exp. Pharmacol. Physiol. 2008; 35: 310-6.
18. Shen Y, Wang CH, Wang YQ, Li F, Zhang W. [Effects of 2, 3, 4′, 5-tetrahydroxystilbene-2-o-(-d-glucoside on content of nitric oxide synthase and expression of nitric oxide synthase in artery vessels of experimental atherosclerotic rats.] Zhongguo Zhong Yao Za Zhi 2008; 33: 919-23. (in Chinese).
19. Zhang W, Xu XL, Wang YQ, Wang CH, Zhu WZ. Effects of 2, 3, 4′, 5-tetrahydroxystilbene-2-o-β-d-glucoside on vascular endothelial dysfunction in atherogenic-diet rats. Planta Med. 2009; 75: 1209-14.
20. Xu XL, Huang YJ, Wang YQ, Chen XF, Zhang W. 2, 3, 4′, 5-Tetrahydroxystilbene-2-o-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle. Clin. Exp. Pharmacol. Physiol. 2011; 38: 307-13.
21. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 1993; 72: 1245-54.
22. Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK. Timing of cyclin D1 expression within G1 phase is controlled by rho. Nat. Cell Biol. 2001; 3: 950-7.
23. Watanabe T, Akishita M, He H et al. 17 Beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor. Biochem. Biophys. Res. Commun. 2003; 311: 454-9.
24. de Souza RR. Aging of myocardial collagen. Biogerontology 2002; 3: 325-35.
25. Iwasaki T, Mukasa K, Yoneda M et al. Marked attenuation of production of collagen type i from cardiac fibroblasts by dehydroepiandrosterone. Am. J. Physiol. Endocrinol. Metab. 2005; 288: E1222-8.
26. Bradham WS, Moe G, Wendt KA et al. TNF-alpha and myocardial matrix metalloproteinases in heart failure: Relationship to LV remodeling. Am. J. Physiol. Heart Circ. Physiol. 2002; 282: H1288-95.
27. He BJ, Joiner ML, Singh MV et al. Oxidation of CAMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 2011; 17: 1610-8.
28. Nishida M, Kitajima N, Saiki S, Nakaya M, Kurose H. Regulation of angiotensin II receptor signaling by cysteine modification of Nf-kappaB. Nitric Oxide 2011; 25: 112-7.
29. Ford WC. Regulation of sperm function by reactive oxygen species. Hum. Reprod. Update 2004; 10: 387-99.
30. Nishida M, Suda R, Nagamatsu Y et al. Pertussis toxin up-regulates angiotensin type 1 receptors through toll-like receptor 4-mediated rac activation. J. Biol. Chem. 2010; 285: 15268-77.
31. Zhao Z, Fefelova N, Shanmugam M, Bishara P, Babu GJ, Xie LH. Angiotensin II induces after depolarizations via reactive oxygen species and calmodulin kinase II signaling. J. Mol. Cell. Cardiol. 2011; 50: 128-36.
32. Liou JY, Hong HJ, Sung LC et al. Nicorandil inhibits angiotensin-II-induced proliferation of cultured rat cardiac fibroblasts. Pharmacology 2011; 87: 144-51.
33. Xie Z, Singh M, Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J. Cell. Physiol. 2004; 198: 399-407.
34. de Lamirande E, Gagnon C. The extracellular signal-regulated kinase (ERK) pathway is involved in human sperm function and modulated by the superoxide anion. Mol. Hum. Reprod. 2002; 8: 124-35.
35. O'Flaherty C, de Lamirande E, Gagnon C. Reactive oxygen species and protein kinases modulate the level of phospho-MEK-like proteins during human sperm capacitation. Biol. Reprod. 2005; 73: 94-105.
36. O'Flaherty C, de Lamirande E, Gagnon C. Reactive oxygen species modulate independent protein phosphorylation pathways during human sperm capacitation. Free Radic. Biol. Med. 2006; 40: 1045-55.
37. Ryu G, Ju JH, Park YJ, Ryu SY, Choi BW, Lee BH. The radical scavenging effects of stilbene glucosides from Polygonum multiflorum. Arch. Pharm. Res. 2002; 25: 636-9.
38. Erhardt P, Schremser EJ, Cooper GM. B-raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol. Cell. Biol. 1999; 19: 5308-15.
39. Almeida RD, Manadas BJ, Melo CV et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005; 12: 1329-43.
40. Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 2009; 8: 1168-75.
41. Diez C, Nestler M, Friedrich U et al. Down-regulation of Akt/Pkb in senescent cardiac fibroblasts impairs Pdgf-induced cell proliferation. Cardiovasc. Res. 2001; 49: 731-40.
42. 2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor. Prostaglandins Leukot. Essent. Fatty Acids 2011; 84: 147-52.
43. He YP, Zhao LY, Zheng QS et al. Involvement of ERK and Akt signaling in the growth effect of arginine vasopressin on adult rat cardiac fibroblast and the modulation by simvastatin. Mol. Cell. Biochem. 2008; 317: 33-41.
44. Tian B, Liu J, Bitterman P, Bache RJ. Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of Akt/PKB. Am. J. Physiol. Heart Circ. Physiol. 2003; 285: H1105-12.